approximately 20-30%. POLICY ON PLACEMENT AND RECRUITING TheBattenGroup and the Organization of Black Aerospace Professionals... mission of OBAP. TheBattenGroup does not discriminate in employment or recruitment practices on the basis of race, color...
will be provided to the candidate of choice. POLICY ON PLACEMENT AND RECRUITING TheBattenGroup and Lupus Foundation of America...Director, Corporate & Industry Partners About Lupus Foundation of America Established nearly 50 years ago, the...
: $100,000-$120,000 POLICY ON PLACEMENT AND RECRUITMENT TheBattenGroup and National Anti-Vivisection Society are equal opportunity employers...Director of Philanthropy About National Anti-Vivisection Society (NAVS) The National Anti-Vivisection Society...
AND RECRUITING TheBattenGroup and Miami Waterkeeper are equal opportunity employers committed to the principles of non... (MWK) is an award-winning non-profit organization dedicated to protecting Biscayne Bay and the surrounding watershed...
. Salary: $70,000 - $80,000 POLICY ON PLACEMENT AND RECRUITING TheBattenGroup and Prevent Cancer Foundation are equal... Foundation We dare to imagine a world where no one dies of cancer. Join us and help make this a reality. The Prevent Cancer...
(the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS..., with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease...
(the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS..., with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease...
(the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS... group is responsible for creating our drugs for use in clinical trials and for scaling production of those drugs for the...
(the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS..., with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease...
(the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS... group is responsible for creating our drugs for use in clinical trials and for scaling production of those drugs for the...